Retina Group of New England — Waterford, Connecticut

Retina Group of New England is a clinical research site located in Waterford, Connecticut, United States 06385.

Crixeo Clinical Trials Trust Score: 24/100 (FAILING). This profile has not yet been claimed by the site owner.

Retina Group of New England has participated in 28 clinical trials with 11 currently active.

Therapeutic areas: Neovascular (Wet) Age-related Macular Degeneration (AMD), Neovascular Age-Related Macular Degeneration (nAMD), Diabetic Macular Edema.

Sponsors: Amgen, Ocular Therapeutix, Inc., Hoffmann-La Roche.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Waterford

Browse all research sites in Connecticut · View every site in Waterford

Sponsor Feasibility Report

Trust Score: 24/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Retina Group of New England?

Retina Group of New England has a Crixeo Trust Score of 24/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Retina Group of New England conducted?

Retina Group of New England has 28 clinical trials on record, with 11 currently active. Their work covers Neovascular (Wet) Age-related Macular Degeneration (AMD), Neovascular Age-Related Macular Degeneration (nAMD), Diabetic Macular Edema.

Is Retina Group of New England accredited by Crixeo Clinical Trials?

Retina Group of New England has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Retina Group of New England?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.